Dr. Cruz Said.......
Being that the first thing Dr. Cruz emphasized about E1-INT on robtv today was the fact that the benefits obtainable from E1-INT are measurable, even with less than 100% decrease in insulin usage, by the improvement to the reduction in complications down the road........I feel compelled to repost my post from last week Feb. 22/07.........
Why Develop Regenerative Medicine??
Some do not understand HOW our Islet Cell Neogenesis Drug E1-INT can benefit the patient if there is only a reduction in insulin usage and not a complete cure. The facts of the matter are that its the long term complications of DB that ends up killing even if insulin does seem to give good quality of life.
The Diabetic Complications 5 - 10 years after Diagnosis are:
-----Infection
-----Blndness
-----Stroke
-----Kidney Disease
-----Amputation
-----Heart Attack
-----Artherosclerosis
Approximately 1 in 10 will die from one or more of these complications.
It is the view that by getting the patients own body to create it's own insulin producing cells that the amount and degree of complications will be drastically reduced even if most never achieve 100% independance from the needle.
Novo will option to further develop this because a decrease in mortality will offset any decrease in use of their insulin products and an increase in the quality of life of the patient as a result of fewer complications is paramount.
https://www.stockhouse.ca/bullboards/viewmessage.asp?no=14262369&tableid=0